CellaVision Fair Value
CE
The fair market value of CEVI.ST stock is 354.7 SEK. Relative to the market price of 242.5 SEK CellaVision is undervalued by 46.3%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
CellaVision Valuation
Current CEVI.ST share ticker price is 242.5 SEK.
The fair value level of 354.7 SEK can be considered as an effective entry point for long-term investors to start investing in CEVI.ST stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 46% lower its fair value
Current price is 7% lower its minimum value
Current price is 113% lower its maximum value
Market price:
CEVI.ST stock is greatly undervalued
It means the current price may concern as a Low Risk Entry Point
CellaVision AB Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
81.79
2
Median P/E over 5 years
56.08
3
Minimum P/E over 5 years
40.88
4
Earning per share (last 12 months)
6.32 SEK
Maximum value
1
x
4
=
517.3 SEK
Fair value
2
x
4
=
354.7 SEK
Minimum value
3
x
4
=
258.54 SEK
CellaVision AB price metrics
-3.04
Annual return (geometric mean)
48.46
Risk (standard deviation) of returns
β
1.08
Beta (volatility compared to market)